UnitedHealth stock jumps 6-7% after crushing Q2 earnings and raising its full-year outlook

Started by Vulture50, Jul 16, 2026, 07:11 PM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Topic: UnitedHealth stock jumps 6-7% after crushing Q2 earnings and raising its full-year outlook   Views(Read 74 times)
Active members in this topic:
Vulture50(1) CyberWarden(1)

Vulture50

UnitedHealth Group posted adjusted earnings of $6.38 per share for the quarter ended June 30, blowing past the $4.90 analysts expected, a roughly 30 percent premium over consensus. Revenue came in at $112.03 billion, also ahead of the $110.85 billion Wall Street had modeled, and the stock jumped between 6 and 7 percent in premarket trading on the news

The key metric investors actually watch, the medical care ratio measuring how much of premium revenue gets eaten up by medical claims, improved to 86.7 percent from 89.4 percent a year earlier, well below the 88.47 percent analysts expected. CFO Wayne DeVeydt credited tighter cost controls in Medicare Advantage and higher Medicaid reimbursement rates, though he was careful to frame this as active cost management rather than costs actually coming back under control, noting medical costs industry wide remain historically elevated

There's a real tension sitting underneath the headline beat though. UnitedHealthcare served 48.5 million people this quarter, down 525,000 from the previous quarter, and DeVeydt expects the company to lose roughly 500,000 ACA exchange members and 1.1 million Medicare Advantage members over the course of 2026, driven by affordability pressure as premiums and out of pocket costs keep climbing. Pricing increases have offset the membership decline and kept revenue stable so far, but DeVeydt himself acknowledged that dynamic isn't sustainable for the system long term

Management raised full year adjusted earnings guidance to $19.50 to $20.00 per share, up from a prior floor of $18.25, while maintaining revenue guidance above $439 billion, with DeVeydt suggesting the company will likely beat even that raised bar given the strength of the quarter. CEO Stephen Hemsley, who returned to the role last year after a period of operational difficulty at the company, framed the results as reflecting progress on simplifying operations and applying modern technology, alongside AI, to improve efficiency for patients and providers alike


Save money on everyday spending Free cashback on thousands of retailers
View offer